Antibiotic Treatment for Well-Appearing Infants Born at ≥35 Weeks’ Gestation to Mothers with Chorioamnionitis Before and After Implementation of Neonatal Early-Onset Sepsis Calculator

Purpose: Our quality improvement study aimed to determine whether application of a neonatal early-onset sepsis calculator (NSC) among well-appearing infants born at ≥ 35 weeks’ gestation to mothers with chorioamnionitis decreases the number of lab evaluations (LEs) and antibiotic treatments (Abxs...

Full description

Bibliographic Details
Main Authors: Surichhya Bajracharya, Preetha Prazad, Catherine Bennett, Nahren Asado
Format: Article
Language:English
Published: Advocate Aurora Health 2024-04-01
Series:Journal of Patient-Centered Research and Reviews
Subjects:
Online Access:https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=2005&context=jpcrr
_version_ 1797224542496620544
author Surichhya Bajracharya
Preetha Prazad
Catherine Bennett
Nahren Asado
author_facet Surichhya Bajracharya
Preetha Prazad
Catherine Bennett
Nahren Asado
author_sort Surichhya Bajracharya
collection DOAJ
description Purpose: Our quality improvement study aimed to determine whether application of a neonatal early-onset sepsis calculator (NSC) among well-appearing infants born at ≥ 35 weeks’ gestation to mothers with chorioamnionitis decreases the number of lab evaluations (LEs) and antibiotic treatments (Abxs) without missing early-onset sepsis. Methods: We compared 2 years (January 1, 2019–January 3, 2021) of data from a historical-control group before implementation of the NSC to 1 year (January 4, 2021–December 31, 2021) of data from a calculator group after implementation of the NSC to evaluate whether LE and Abx decreased following implementation of the NSC on January 4, 2021. A P-value of < 0.05 was considered statistically significant for the chi-squared test, Fisher’s exact test, Student’s t-test, and Mann-Whitney U test used for the analyses. Results: In the historical-control group, 94% of infants received LE and Abx. Retrospective application of the NSC in the historical-control group decreased LE from 94% to 21% and Abx from 94% to 13%. In the calculator group, 14% and 5% of infants received LE and Abx, respectively, and none of the blood culture was positive. Median time from birth to antibiotic initiation was significantly longer (14.5 vs 3.8 hours; P = 0.0037) with no increase in median length of stay (2.3 vs 2.4 days; P = 0.02) after NSC implementation. No significant difference in neonatal intensive care unit admission was identified between groups (4% vs 1%; P = 0.15). Conclusions: There was a significant decrease in LE and Abx among well-appearing infants born at ≥ 35 weeks’ gestation to mothers with chorioamnionitis after implementation of the NSC without missing early-onset sepsis. There was no increase in neonatal intensive care unit admission or length of hospital stay in infants who received antibiotics later after they appeared equivocal or clinically ill in the calculator group. Larger prospective studies that include follow ups are needed to confirm that early-onset sepsis is not missed. (J Patient Cent Res Rev. 2024;11:29-35.)
first_indexed 2024-04-24T13:54:46Z
format Article
id doaj.art-83a7a80044834c2caca77968884430cb
institution Directory Open Access Journal
issn 2330-0698
language English
last_indexed 2024-04-24T13:54:46Z
publishDate 2024-04-01
publisher Advocate Aurora Health
record_format Article
series Journal of Patient-Centered Research and Reviews
spelling doaj.art-83a7a80044834c2caca77968884430cb2024-04-03T19:24:19ZengAdvocate Aurora HealthJournal of Patient-Centered Research and Reviews2330-06982024-04-01111293510.17294/2330-0698.2005Antibiotic Treatment for Well-Appearing Infants Born at ≥35 Weeks’ Gestation to Mothers with Chorioamnionitis Before and After Implementation of Neonatal Early-Onset Sepsis CalculatorSurichhya Bajracharya0Preetha Prazad1https://orcid.org/0000-0001-9120-4575Catherine Bennett2Nahren Asado3Neonatal Perinatal Medicine, Advocate Children’s Hospital, Park Ridge, ILNeonatal Perinatal Medicine, Advocate Children’s Hospital, Park Ridge, ILObstetrics and Gynecology, Advocate Lutheran General Hospital, Park Ridge, ILPathology, Advocate Lutheran General Hospital, Park Ridge, ILPurpose: Our quality improvement study aimed to determine whether application of a neonatal early-onset sepsis calculator (NSC) among well-appearing infants born at ≥ 35 weeks’ gestation to mothers with chorioamnionitis decreases the number of lab evaluations (LEs) and antibiotic treatments (Abxs) without missing early-onset sepsis. Methods: We compared 2 years (January 1, 2019–January 3, 2021) of data from a historical-control group before implementation of the NSC to 1 year (January 4, 2021–December 31, 2021) of data from a calculator group after implementation of the NSC to evaluate whether LE and Abx decreased following implementation of the NSC on January 4, 2021. A P-value of < 0.05 was considered statistically significant for the chi-squared test, Fisher’s exact test, Student’s t-test, and Mann-Whitney U test used for the analyses. Results: In the historical-control group, 94% of infants received LE and Abx. Retrospective application of the NSC in the historical-control group decreased LE from 94% to 21% and Abx from 94% to 13%. In the calculator group, 14% and 5% of infants received LE and Abx, respectively, and none of the blood culture was positive. Median time from birth to antibiotic initiation was significantly longer (14.5 vs 3.8 hours; P = 0.0037) with no increase in median length of stay (2.3 vs 2.4 days; P = 0.02) after NSC implementation. No significant difference in neonatal intensive care unit admission was identified between groups (4% vs 1%; P = 0.15). Conclusions: There was a significant decrease in LE and Abx among well-appearing infants born at ≥ 35 weeks’ gestation to mothers with chorioamnionitis after implementation of the NSC without missing early-onset sepsis. There was no increase in neonatal intensive care unit admission or length of hospital stay in infants who received antibiotics later after they appeared equivocal or clinically ill in the calculator group. Larger prospective studies that include follow ups are needed to confirm that early-onset sepsis is not missed. (J Patient Cent Res Rev. 2024;11:29-35.)https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=2005&context=jpcrrneonatalearly-onset sepsiscalculatorchorioamnioitis
spellingShingle Surichhya Bajracharya
Preetha Prazad
Catherine Bennett
Nahren Asado
Antibiotic Treatment for Well-Appearing Infants Born at ≥35 Weeks’ Gestation to Mothers with Chorioamnionitis Before and After Implementation of Neonatal Early-Onset Sepsis Calculator
Journal of Patient-Centered Research and Reviews
neonatal
early-onset sepsis
calculator
chorioamnioitis
title Antibiotic Treatment for Well-Appearing Infants Born at ≥35 Weeks’ Gestation to Mothers with Chorioamnionitis Before and After Implementation of Neonatal Early-Onset Sepsis Calculator
title_full Antibiotic Treatment for Well-Appearing Infants Born at ≥35 Weeks’ Gestation to Mothers with Chorioamnionitis Before and After Implementation of Neonatal Early-Onset Sepsis Calculator
title_fullStr Antibiotic Treatment for Well-Appearing Infants Born at ≥35 Weeks’ Gestation to Mothers with Chorioamnionitis Before and After Implementation of Neonatal Early-Onset Sepsis Calculator
title_full_unstemmed Antibiotic Treatment for Well-Appearing Infants Born at ≥35 Weeks’ Gestation to Mothers with Chorioamnionitis Before and After Implementation of Neonatal Early-Onset Sepsis Calculator
title_short Antibiotic Treatment for Well-Appearing Infants Born at ≥35 Weeks’ Gestation to Mothers with Chorioamnionitis Before and After Implementation of Neonatal Early-Onset Sepsis Calculator
title_sort antibiotic treatment for well appearing infants born at ≥35 weeks gestation to mothers with chorioamnionitis before and after implementation of neonatal early onset sepsis calculator
topic neonatal
early-onset sepsis
calculator
chorioamnioitis
url https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=2005&context=jpcrr
work_keys_str_mv AT surichhyabajracharya antibiotictreatmentforwellappearinginfantsbornat35weeksgestationtomotherswithchorioamnionitisbeforeandafterimplementationofneonatalearlyonsetsepsiscalculator
AT preethaprazad antibiotictreatmentforwellappearinginfantsbornat35weeksgestationtomotherswithchorioamnionitisbeforeandafterimplementationofneonatalearlyonsetsepsiscalculator
AT catherinebennett antibiotictreatmentforwellappearinginfantsbornat35weeksgestationtomotherswithchorioamnionitisbeforeandafterimplementationofneonatalearlyonsetsepsiscalculator
AT nahrenasado antibiotictreatmentforwellappearinginfantsbornat35weeksgestationtomotherswithchorioamnionitisbeforeandafterimplementationofneonatalearlyonsetsepsiscalculator